Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5183218
Max Phase: Preclinical
Molecular Formula: C32H28N5O15P3
Molecular Weight: 815.52
Associated Items:
ID: ALA5183218
Max Phase: Preclinical
Molecular Formula: C32H28N5O15P3
Molecular Weight: 815.52
Associated Items:
Canonical SMILES: Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](OC(=O)c2cccc3ccccc23)[C@H]1OC(=O)c1cccc2ccccc12
Standard InChI: InChI=1S/C32H28N5O15P3/c33-28-25-29(35-16-34-28)37(17-36-25)30-27(50-32(39)23-14-6-10-19-8-2-4-12-21(19)23)26(49-31(38)22-13-5-9-18-7-1-3-11-20(18)22)24(48-30)15-47-54(43,44)52-55(45,46)51-53(40,41)42/h1-14,16-17,24,26-27,30H,15H2,(H,43,44)(H,45,46)(H2,33,34,35)(H2,40,41,42)/t24-,26-,27-,30-/m1/s1
Standard InChI Key: PSBROSWEMLTASJ-BQOYKFDPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 815.52 | Molecular Weight (Monoisotopic): 815.0795 | AlogP: 4.41 | #Rotatable Bonds: 12 |
Polar Surface Area: 291.27 | Molecular Species: ACID | HBA: 16 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 20 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 0.90 | CX Basic pKa: 4.92 | CX LogP: 1.61 | CX LogD: -3.50 |
Aromatic Rings: 6 | Heavy Atoms: 55 | QED Weighted: 0.08 | Np Likeness Score: 0.60 |
1. Isaak A, Dobelmann C, Füsser FT, Erlitz KS, Koch O, Junker A.. (2022) Unveiling the Structure-Activity Relationships at the Orthosteric Binding Site of P2X Ion Channels: The Route to Selectivity., 65 (16.0): [PMID:35930402] [10.1021/acs.jmedchem.2c00812] |
Source(1):